Global Extremity Reconstruction

Extremity Reconstruction Comprehensive Study by Type (Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction), Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))), Application (Trauma or cancer removal.), End User (Hospitals, Clinic, Others), Biomaterials (Metallic, Polymeric, Ceramic, Natural) Players and Region - Global Market Outlook to 2029

Extremity Reconstruction Market by XX Submarkets | Forecast Years 2024-2029  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Extremity Reconstruction Market Scope
Owing to the increasing number of patients suffering from cancers, chronic diseases, and accident-related injuries that result in the removal of extremities, it is becoming increasingly important for developments in this field to take up greater investments from the healthcare industry. Extremity reconstruction may be necessary after trauma or cancer removal. The arms and legs are important areas of the body, and extremity wounds can greatly affect mobility and lifestyle. Upper-extremity reconstruction can improve function for people with catastrophic spinal cord or brain injuries who have limited function in their arms, wrists, and hands. The rising number of cases of abnormalities and injuries in the lower and upper extremities of the human body encourages the growth of the global market in the forecasted period. In addition, technological advancements in extremity reconstruction devices and advancement in healthcare infrastructure are anticipated to accelerate the development of the market in the near future.

AttributesDetails
Study Period2019-2029
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledZimmer Biomet (United States), Wright Medical Group N.V (Netherlands), CONMED Corporation (United States), Acumed, LLC (United States), Arthrex (United States), DePuy Synthes (United States), Stryker Corporation (United States), Smith & Nephew plc (United Kingdom) and Integra Lifesciences Holdings Corporation (United States)
CAGR%


Leading global players are focusing on strategic partnerships to improve their products and services. The top firms are in a competition that has their strong R&D backup for research studies and the further things which are required to get approval for new devices. Mergers and acquisitions are other options to change the market strategies and earn more reputation in the market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Extremity Reconstruction market throughout the predicted period.

Zimmer Biomet (United States), Wright Medical Group N.V (Netherlands), CONMED Corporation (United States), Acumed, LLC (United States), Arthrex (United States), DePuy Synthes (United States), Stryker Corporation (United States), Smith & Nephew plc (United Kingdom) and Integra Lifesciences Holdings Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Skeletal Dynamics LLC. (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Extremity Reconstruction market by Type , by Application (trauma or cancer removal.) and Region with country level break-up.

On the basis of geography, the market of Extremity Reconstruction has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In April 2019, Acumed, a leading manufacturer of orthopaedic surgical solutions, is pleased to announce the acquisition of technology that will help the company provide a total elbow arthroplasty (TEA) solution to the market. Acumed Acquires New Elbow Arthroplasty Technology.
In May 2020, Integra LifeSciences Holding Corporation announced positive clinical and economic data on Integra® Bilayer Wound Matrix (IBWM) in complex lower extremity reconstruction.


Influencing Trend:
Technological Innovations in the Field of Extremity Implants

Market Growth Drivers:
Increase in the Number of Joint Disorders such as Osteoarthritis and Rheumatoid Arthritis and Rising Geriatric Population

Challenges:
Failures & Complications Associated with the Surgery

Restraints:
Hig Cost of Treatment

Opportunities:
Increasing Awareness among Patients about the Benefits of Joint Reconstruction Implants and Advancements in the Healthcare Infrastructure in Developing Countries

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Extremity Reconstruction Providers, Extremity Reconstruction Equipment Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Report Objectives / Segmentation Covered

By Type
  • Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction)
  • Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))
By Application
  • trauma or cancer removal.
By End User
  • Hospitals
  • Clinic
  • Others

By Biomaterials
  • Metallic
  • Polymeric
  • Ceramic
  • Natural

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Number of Joint Disorders such as Osteoarthritis and Rheumatoid Arthritis
      • 3.2.2. Rising Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Failures & Complications Associated with the Surgery
    • 3.4. Market Trends
      • 3.4.1. Technological Innovations in the Field of Extremity Implants
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Extremity Reconstruction, by Type, Application, End User, Biomaterials and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Extremity Reconstruction (Value)
      • 5.2.1. Global Extremity Reconstruction by: Type (Value)
        • 5.2.1.1. Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction)
        • 5.2.1.2. Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))
      • 5.2.2. Global Extremity Reconstruction by: Application (Value)
        • 5.2.2.1. Trauma or cancer removal.
      • 5.2.3. Global Extremity Reconstruction by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinic
        • 5.2.3.3. Others
      • 5.2.4. Global Extremity Reconstruction by: Biomaterials (Value)
        • 5.2.4.1. Metallic
        • 5.2.4.2. Polymeric
        • 5.2.4.3. Ceramic
        • 5.2.4.4. Natural
      • 5.2.5. Global Extremity Reconstruction Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Extremity Reconstruction (Price)
      • 5.3.1. Global Extremity Reconstruction by: Type (Price)
  • 6. Extremity Reconstruction: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zimmer Biomet (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Wright Medical Group N.V (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CONMED Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Acumed, LLC (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Arthrex (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. DePuy Synthes (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Stryker Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Smith & Nephew plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Integra Lifesciences Holdings Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Extremity Reconstruction Sale, by Type, Application, End User, Biomaterials and Region (value and price ) (2024-2029)
    • 7.1. Introduction
    • 7.2. Global Extremity Reconstruction (Value)
      • 7.2.1. Global Extremity Reconstruction by: Type (Value)
        • 7.2.1.1. Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction)
        • 7.2.1.2. Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))
      • 7.2.2. Global Extremity Reconstruction by: Application (Value)
        • 7.2.2.1. Trauma or cancer removal.
      • 7.2.3. Global Extremity Reconstruction by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinic
        • 7.2.3.3. Others
      • 7.2.4. Global Extremity Reconstruction by: Biomaterials (Value)
        • 7.2.4.1. Metallic
        • 7.2.4.2. Polymeric
        • 7.2.4.3. Ceramic
        • 7.2.4.4. Natural
      • 7.2.5. Global Extremity Reconstruction Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Extremity Reconstruction (Price)
      • 7.3.1. Global Extremity Reconstruction by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Extremity Reconstruction: by Type(USD Million)
  • Table 2. Extremity Reconstruction Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction) , by Region USD Million (2018-2023)
  • Table 3. Extremity Reconstruction Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement)) , by Region USD Million (2018-2023)
  • Table 4. Extremity Reconstruction: by Application(USD Million)
  • Table 5. Extremity Reconstruction Trauma or cancer removal. , by Region USD Million (2018-2023)
  • Table 6. Extremity Reconstruction: by End User(USD Million)
  • Table 7. Extremity Reconstruction Hospitals , by Region USD Million (2018-2023)
  • Table 8. Extremity Reconstruction Clinic , by Region USD Million (2018-2023)
  • Table 9. Extremity Reconstruction Others , by Region USD Million (2018-2023)
  • Table 10. Extremity Reconstruction: by Biomaterials(USD Million)
  • Table 11. Extremity Reconstruction Metallic , by Region USD Million (2018-2023)
  • Table 12. Extremity Reconstruction Polymeric , by Region USD Million (2018-2023)
  • Table 13. Extremity Reconstruction Ceramic , by Region USD Million (2018-2023)
  • Table 14. Extremity Reconstruction Natural , by Region USD Million (2018-2023)
  • Table 15. South America Extremity Reconstruction, by Country USD Million (2018-2023)
  • Table 16. South America Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 17. South America Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 18. South America Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 19. South America Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 20. Brazil Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 21. Brazil Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 22. Brazil Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 23. Brazil Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 24. Argentina Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 25. Argentina Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 26. Argentina Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 27. Argentina Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 28. Rest of South America Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 29. Rest of South America Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 30. Rest of South America Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 31. Rest of South America Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 32. Asia Pacific Extremity Reconstruction, by Country USD Million (2018-2023)
  • Table 33. Asia Pacific Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 34. Asia Pacific Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 35. Asia Pacific Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 36. Asia Pacific Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 37. China Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 38. China Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 39. China Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 40. China Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 41. Japan Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 42. Japan Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 43. Japan Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 44. Japan Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 45. India Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 46. India Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 47. India Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 48. India Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 49. South Korea Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 50. South Korea Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 51. South Korea Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 52. South Korea Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 53. Taiwan Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 54. Taiwan Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 55. Taiwan Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 56. Taiwan Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 57. Australia Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 58. Australia Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 59. Australia Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 60. Australia Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 65. Europe Extremity Reconstruction, by Country USD Million (2018-2023)
  • Table 66. Europe Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 67. Europe Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 68. Europe Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 69. Europe Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 70. Germany Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 71. Germany Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 72. Germany Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 73. Germany Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 74. France Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 75. France Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 76. France Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 77. France Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 78. Italy Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 79. Italy Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 80. Italy Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 81. Italy Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 82. United Kingdom Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 83. United Kingdom Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 84. United Kingdom Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 85. United Kingdom Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 86. Netherlands Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 87. Netherlands Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 88. Netherlands Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 89. Netherlands Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 90. Rest of Europe Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 91. Rest of Europe Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 92. Rest of Europe Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 93. Rest of Europe Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 94. MEA Extremity Reconstruction, by Country USD Million (2018-2023)
  • Table 95. MEA Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 96. MEA Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 97. MEA Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 98. MEA Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 99. Middle East Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 100. Middle East Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 101. Middle East Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 102. Middle East Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 103. Africa Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 104. Africa Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 105. Africa Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 106. Africa Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 107. North America Extremity Reconstruction, by Country USD Million (2018-2023)
  • Table 108. North America Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 109. North America Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 110. North America Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 111. North America Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 112. United States Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 113. United States Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 114. United States Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 115. United States Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 116. Canada Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 117. Canada Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 118. Canada Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 119. Canada Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 120. Mexico Extremity Reconstruction, by Type USD Million (2018-2023)
  • Table 121. Mexico Extremity Reconstruction, by Application USD Million (2018-2023)
  • Table 122. Mexico Extremity Reconstruction, by End User USD Million (2018-2023)
  • Table 123. Mexico Extremity Reconstruction, by Biomaterials USD Million (2018-2023)
  • Table 124. Extremity Reconstruction: by Type(USD/Units)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Extremity Reconstruction: by Type(USD Million)
  • Table 135. Extremity Reconstruction Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction) , by Region USD Million (2024-2029)
  • Table 136. Extremity Reconstruction Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement)) , by Region USD Million (2024-2029)
  • Table 137. Extremity Reconstruction: by Application(USD Million)
  • Table 138. Extremity Reconstruction Trauma or cancer removal. , by Region USD Million (2024-2029)
  • Table 139. Extremity Reconstruction: by End User(USD Million)
  • Table 140. Extremity Reconstruction Hospitals , by Region USD Million (2024-2029)
  • Table 141. Extremity Reconstruction Clinic , by Region USD Million (2024-2029)
  • Table 142. Extremity Reconstruction Others , by Region USD Million (2024-2029)
  • Table 143. Extremity Reconstruction: by Biomaterials(USD Million)
  • Table 144. Extremity Reconstruction Metallic , by Region USD Million (2024-2029)
  • Table 145. Extremity Reconstruction Polymeric , by Region USD Million (2024-2029)
  • Table 146. Extremity Reconstruction Ceramic , by Region USD Million (2024-2029)
  • Table 147. Extremity Reconstruction Natural , by Region USD Million (2024-2029)
  • Table 148. South America Extremity Reconstruction, by Country USD Million (2024-2029)
  • Table 149. South America Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 150. South America Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 151. South America Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 152. South America Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 153. Brazil Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 154. Brazil Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 155. Brazil Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 156. Brazil Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 157. Argentina Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 158. Argentina Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 159. Argentina Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 160. Argentina Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 161. Rest of South America Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 162. Rest of South America Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 163. Rest of South America Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 164. Rest of South America Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 165. Asia Pacific Extremity Reconstruction, by Country USD Million (2024-2029)
  • Table 166. Asia Pacific Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 167. Asia Pacific Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 168. Asia Pacific Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 169. Asia Pacific Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 170. China Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 171. China Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 172. China Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 173. China Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 174. Japan Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 175. Japan Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 176. Japan Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 177. Japan Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 178. India Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 179. India Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 180. India Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 181. India Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 182. South Korea Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 183. South Korea Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 184. South Korea Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 185. South Korea Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 186. Taiwan Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 187. Taiwan Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 188. Taiwan Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 189. Taiwan Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 190. Australia Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 191. Australia Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 192. Australia Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 193. Australia Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 194. Rest of Asia-Pacific Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 195. Rest of Asia-Pacific Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 196. Rest of Asia-Pacific Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 197. Rest of Asia-Pacific Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 198. Europe Extremity Reconstruction, by Country USD Million (2024-2029)
  • Table 199. Europe Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 200. Europe Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 201. Europe Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 202. Europe Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 203. Germany Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 204. Germany Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 205. Germany Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 206. Germany Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 207. France Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 208. France Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 209. France Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 210. France Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 211. Italy Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 212. Italy Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 213. Italy Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 214. Italy Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 215. United Kingdom Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 216. United Kingdom Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 217. United Kingdom Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 218. United Kingdom Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 219. Netherlands Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 220. Netherlands Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 221. Netherlands Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 222. Netherlands Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 223. Rest of Europe Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 224. Rest of Europe Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 225. Rest of Europe Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 226. Rest of Europe Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 227. MEA Extremity Reconstruction, by Country USD Million (2024-2029)
  • Table 228. MEA Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 229. MEA Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 230. MEA Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 231. MEA Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 232. Middle East Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 233. Middle East Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 234. Middle East Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 235. Middle East Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 236. Africa Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 237. Africa Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 238. Africa Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 239. Africa Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 240. North America Extremity Reconstruction, by Country USD Million (2024-2029)
  • Table 241. North America Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 242. North America Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 243. North America Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 244. North America Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 245. United States Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 246. United States Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 247. United States Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 248. United States Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 249. Canada Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 250. Canada Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 251. Canada Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 252. Canada Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 253. Mexico Extremity Reconstruction, by Type USD Million (2024-2029)
  • Table 254. Mexico Extremity Reconstruction, by Application USD Million (2024-2029)
  • Table 255. Mexico Extremity Reconstruction, by End User USD Million (2024-2029)
  • Table 256. Mexico Extremity Reconstruction, by Biomaterials USD Million (2024-2029)
  • Table 257. Extremity Reconstruction: by Type(USD/Units)
  • Table 258. Research Programs/Design for This Report
  • Table 259. Key Data Information from Secondary Sources
  • Table 260. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Extremity Reconstruction: by Type USD Million (2018-2023)
  • Figure 5. Global Extremity Reconstruction: by Application USD Million (2018-2023)
  • Figure 6. Global Extremity Reconstruction: by End User USD Million (2018-2023)
  • Figure 7. Global Extremity Reconstruction: by Biomaterials USD Million (2018-2023)
  • Figure 8. South America Extremity Reconstruction Share (%), by Country
  • Figure 9. Asia Pacific Extremity Reconstruction Share (%), by Country
  • Figure 10. Europe Extremity Reconstruction Share (%), by Country
  • Figure 11. MEA Extremity Reconstruction Share (%), by Country
  • Figure 12. North America Extremity Reconstruction Share (%), by Country
  • Figure 13. Global Extremity Reconstruction: by Type USD/Units (2018-2023)
  • Figure 14. Global Extremity Reconstruction share by Players 2023 (%)
  • Figure 15. Global Extremity Reconstruction share by Players (Top 3) 2023(%)
  • Figure 16. Global Extremity Reconstruction share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Zimmer Biomet (United States) Revenue, Net Income and Gross profit
  • Figure 19. Zimmer Biomet (United States) Revenue: by Geography 2023
  • Figure 20. Wright Medical Group N.V (Netherlands) Revenue, Net Income and Gross profit
  • Figure 21. Wright Medical Group N.V (Netherlands) Revenue: by Geography 2023
  • Figure 22. CONMED Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. CONMED Corporation (United States) Revenue: by Geography 2023
  • Figure 24. Acumed, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 25. Acumed, LLC (United States) Revenue: by Geography 2023
  • Figure 26. Arthrex (United States) Revenue, Net Income and Gross profit
  • Figure 27. Arthrex (United States) Revenue: by Geography 2023
  • Figure 28. DePuy Synthes (United States) Revenue, Net Income and Gross profit
  • Figure 29. DePuy Synthes (United States) Revenue: by Geography 2023
  • Figure 30. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Stryker Corporation (United States) Revenue: by Geography 2023
  • Figure 32. Smith & Nephew plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Smith & Nephew plc (United Kingdom) Revenue: by Geography 2023
  • Figure 34. Integra Lifesciences Holdings Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Integra Lifesciences Holdings Corporation (United States) Revenue: by Geography 2023
  • Figure 36. Global Extremity Reconstruction: by Type USD Million (2024-2029)
  • Figure 37. Global Extremity Reconstruction: by Application USD Million (2024-2029)
  • Figure 38. Global Extremity Reconstruction: by End User USD Million (2024-2029)
  • Figure 39. Global Extremity Reconstruction: by Biomaterials USD Million (2024-2029)
  • Figure 40. South America Extremity Reconstruction Share (%), by Country
  • Figure 41. Asia Pacific Extremity Reconstruction Share (%), by Country
  • Figure 42. Europe Extremity Reconstruction Share (%), by Country
  • Figure 43. MEA Extremity Reconstruction Share (%), by Country
  • Figure 44. North America Extremity Reconstruction Share (%), by Country
  • Figure 45. Global Extremity Reconstruction: by Type USD/Units (2024-2029)
List of companies from research coverage that are profiled in the study
  • Zimmer Biomet (United States)
  • Wright Medical Group N.V (Netherlands)
  • CONMED Corporation (United States)
  • Acumed, LLC (United States)
  • Arthrex (United States)
  • DePuy Synthes (United States)
  • Stryker Corporation (United States)
  • Smith & Nephew plc (United Kingdom)
  • Integra Lifesciences Holdings Corporation (United States)
Additional players considered in the study are as follows:
Skeletal Dynamics LLC. (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 207 Pages 78 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Extremity Reconstruction Quantitative research analysis
Global Extremity Reconstruction Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Extremity Reconstruction Market are by type [Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction) and Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))], by end use application [trauma or cancer removal.].
The Extremity Reconstruction Market is gaining popularity and expected to see strong valuation by 2029.
  • Increase in the Number of Joint Disorders such as Osteoarthritis and Rheumatoid Arthritis
  • Rising Geriatric Population

Know More About Global Extremity Reconstruction Report?

Have a Query? Click Here

Other Related Reports

Pediatric Brain Tumor Comprehensive Study by Type (Gliomas, Mixed neuronal-glial tumors, Embryonal tumors, Choroid plexus papilloma/carcinoma, Non-neuroepithelial tissue tumors, Meningeal Tumors, Oth...
$ 3500
Head and Neck Cancer Diagnostics Comprehensive Study by Type (Diagnostic imaging equipment, Endoscopy screening equipment, Bioscopy screening tests, Blood tests, Dental diagnostic), Application (Hosp...
$ 3750
Implantable Heart Pacemaker Comprehensive Study by Type (Single Chamber, Dual-Chamber, Biventricular Pacemaking), Application (Heart Block, Sick Sinus Syndrome, Diagnosing Heart Diseases, Others), Pa...
$ 3650
Orthopaedics Comprehensive Study by Application (Fracture Management, Joint Replacement, Orthopedic Surgery, Pediatric Assessment, Pediatric Assessment), Area of Treatment (Trauma, Spine, Knee, Hip),...
$ 3350
Type 1 Diabetes Comprehensive Study by Application (Hospitals, Diagnostic clinics), End Users (Adults, Hospitals and Clinics, Homecare Providers), Product (Insulin, Blood Glucose Monitoring Devices, ...
$ 3500
Food Allergy Comprehensive Study by Type (Corn Allergy, Egg Allergy, Fish Allergy, Meat Allergy, Milk Allergy, Peanut Allergy, Shellfish Allergy, Soy Allergy, Tree Nut Allergy, Wheat Allergy, Others)...
$ 3750